NCT00034346
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +16 more
- Locations
-
Not specified
Clinical trial condition
Carcinoma, Bronchogenic
Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.
5,235 public trials
1,182 recruiting studies
Carcinoma, Bronchogenic trial results
Completed
Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy
NCT00120679
- Conditions
- Anemia, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
Not specified
NCT00089726
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT00069875
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Birmingham, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Boston, Massachusetts, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Manhasset, New York, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Durham, North Carolina, United States
NCT00578149
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00333294
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Clermont-Ferrand, France
- Research Site Grenoble, France
- Research Site Nantes, France
- Research SIte Paris, France
NCT00252798
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Woolloonabba, Queensland, Australia
- Research Site East Melbourne, Victoria, Australia
Completed
Iressa 2nd Line Phase III Study in Japan
NCT00252707
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Nagoya, Aichi-ken, Japan
- Research Site Okazaki, Aichi-ken, Japan
- Research Site Hirosaki, Aomori, Japan
- Research Site Kashiwa, Chiba, Japan
NCT00073151
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Oncology Hematology Group of South Florida Miami, Florida, United States
- Florida Cancer Institute New Port Richey, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- University of Maryland Greenbaum Cancer Center Baltimore, Maryland, United States
Completed
Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC
NCT00259675
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Saskatoon cancer ctr Saskatoon, Saskatchewan, Canada